Compare AbCellera Biologics Inc (ABCL) vs Flagstar Bank NA (FLG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Flagstar Bank NA — how do they compare? AbCellera Biologics Inc trades at $9.05 (market cap $2.99B), while Flagstar Bank NA trades at $14.23 (market cap $5.89B). The key difference: Flagstar Bank NA is the larger of the two by market cap, and Flagstar Bank NA pays a 0.28% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | FLG | |
|---|---|---|
Market Cap | $2.99B | $5.89B |
Sector | Health | Financials |
52-Week High | $9.76 | $15.36 |
52-Week Low | $2.78 | $10.72 |
Enterprise Value | $2.58B | — |
Dividend Yield | — | 0.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Flagstar Bank NA
Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →
